+86 025-52110956                                   sales@liskonchem.com

手机网站1
手机网站2

Hot Chemicals

TEMPO
CAS No.: 2564-83-2
CARBOXIN
CAS No.: 5234-68-4
2, 2, 6, 6- TETRAMETHYLPIPERIDINE
CAS No.: 768-66-1
CYMOXANIL
CAS No.: 57966-95-7
4-HYDROXY-TEMPO
CAS No.: 2226-96-2
4-NITROBENZOIC ACID
CAS No.: 62-23-7
CYCLOBUTANONE
CAS No.: 1191-95-3
2,2,6,6-TETRAMETHYL-4-PIPERIDINOL
CAS No.: 2403-88-5

Who we are?

Professional TEMPO Manufacturer - Liskon

Many years of experience in the production of TEMPO  

Nanjing Liskon Biological Technology Co., Ltd. is a high-tech enterprise focusing on chemicals development, production, sales, import and export trade. TEMPO(CAS No.: 2564-83-2), TEMP(CAS No.: 768-66-1), 4-Nitrobenzoic acid(CAS No.: 62-23-7), Carboxin 98%TC, Dimethomorph 98%TC, Cymoxanil 98%TC are our very competitive products.

0+
Employees
0+
Million Dollars
0+
Square Meter Area
0+
Partner

APPLICATION INDUSTRY

BLOG

tempo 2564-83-2 photo.png
Detailed study about oxidizing alcohols to aldehydes by TEMPO free radical

This article is mainly about the principle of TEMPO free radical(2,2,6,6-tetramethylpiperidine-1-oxyl, 2564-83-2) oxidation, why the reaction can be selective and how to reduce the consumption of TEMPO. Presented by NanJing Liskon Biological Technology Co.,ltd.

2021-09-14
tempo radical.jpg
TEMPO oxidizes alcohols to aldehydes and ketones

TEMPO oxidizes alcohols to aldehydes and ketonesIn 1987, Anelli reported the oxidation of alcohols to aldehydes and ketones using TEMPO (CA.1% mol), NaOCl, KBr and NaHCO3 in dichloromethane - water two-phase solvent.TEMPO also called 2,2,6,6-tetramethylpiperidine-1-oxide, or 2,2,6,6-tetramethylpiper

2021-08-16
TEMPOL has potential in treatment for COVID-19.jpg
TEMPOL has potential in treatment for COVID-19

SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today highlighted that the NIH has identified Tempol as a potential home treatment for COVID-19 (TEMPOL: A Potential Home Treatment for COVID-19 | NIH COVID-19 Research). The NIH news stated that, “This tre

2021-08-20
fda.jpg
Zhejiang Hisun's new drug approved by US FDA

A new drug of datoromycin for injection developed by Zhejiang Hisun Pharmaceutical Co.,ltd has been approved by the U.S. Food and Drug Administration(FDA). It means that the applicant can produce and sell the product in the U.S. market.Daptomycin for injection is suitable for the treatment of: 1. Co

2021-06-30